.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

How our clients use DrugPatentWatch

Pharmaceutical Business Intelligence

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Other DrugPatentWatch Resources

Some biosimilars are just as good as some pricey biologics

A new study suggests that a group of biosimilar drugs, which are used to treat such afflictions as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, appear as safe and effective as their more expensive brand-name counterparts, which are known as biologics. A biosimilar drug is a nearly identical variant of a biologic and is expected to…

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact us or visit www.DrugPatentWatch.com

Back to DrugPatentWatch Resources

For more information try a trial or see the database preview and plans and pricing

`abc